Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Attendees who have favorited this...
Anne Broe
IQVIA (UK)
Shih-Wei Chiu
Tohoku University Graduate School of Medicine
HuiMin Chuang
Taiwan Drug Relief Foundation
Pernille Cromhout
Post Doc
Novo Nordisk A/S
Jeremy Furtado
Associate Director, Epidemiology
Biogen
Shiyao Gao
Xabier Garcia de Albeniz
RTI Health Solutions
Jennifer Gerber
Associate Director, Epidemiology
GSK
Jia Guan
RWE STAT Advisor
Boehringer Ingelheim
Katrina Hagberg
Boston Collaborative Drug Surveillance Program
Janet Hardy
Head of Pharmacoepidemiology
Biohaven Pharmaceuticals
Christian Jonasson
Research Director
NordicRWE
Oystein Karlstad
Senior researcher
Norwegian Institute of Public Health
Sangmi Kim
Eli Lilly & Company
Hopin Lee
Senior Consultant
IQVIA
Sukhyang Lee
Hu Li
Gilead Sciences
Alexander Liede
Sr Director, Head of Evidence & Partnerships, Global Epidemiology, AbbVie
AbbVie
Zhiwen Liu
Janssen Pharmaceuticals, Inc.
Camille Maringe
Assistant Professor
Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine
Kristin Meyers
Director
Eli Lilly and Company
Danielle Newby
CSM, NDORMS, University of Oxford
Kaori Nomura
MPH, PhD, RPh
tonny petersen
Consultant, clinical associate professor
department of clinical pharmacology, Bispebjerg Gospital Denmark
Lawrence Rasouliyan
Head, Biostatistics & Data Science
OMNY Health
Erle Refsum
Norwegian Institute of Public Health
Lina Sy
Kaiser Permanente Southern California, Department of Research & Evaluation
Wenze Tang
Manager
Johnson & Johnson
Lina Titievsky
Senior Director
vertex pharmaceuticals
Huifen Wang
HUIFEN WANG
Brandy Winquist Bang
Adjunct Professor
University of Saskatchewan
Fei Yang
Principal Quantitative Scientist
F. Hoffmann-La Roche AG
Kuen-Cheh Yang
Vertex Pharmaceuticals, Inc.
